Founded in 2018, ELMED Life Sciences operates in Health Tech offering science-driven microbiome solutions that advance the Global One Health approach across human health, animal health, and agricultur...
Funding stage:
Series A
Last funding:
25/03/2026
Total funding:
$2.70 Mn+
Revenue:
Investors
Employee count:
60
Last 90d
60
Last 90d
Web traffic:
66
66
Last 30d
Last 30d
ELMED Life Sciences: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders3
Latest Filing Date30 March 2023- Funding Events8
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of ELMED Life Sciences
As of 31 March 2023, ELMED Life Sciences's equity is held by 3 shareholders, with the top three being Pruthivin Reddy, Nikhil Konkathi, and Parvathi Karnata.
Pruthivin Reddy holds the largest stake in ELMED Life Sciences at 41.0% as of 31 March 2023.
As of 31 March 2023, founders collectively hold 80.1% equity in ELMED Life Sciences.
As of 31 March 2023, investors collectively hold 19.9% equity in ELMED Life Sciences.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links